Archives of Dermatological Research

, Volume 302, Issue 8, pp 601–607 | Cite as

Increased angiogenesis and mast cells in the centre compared to the periphery of vitiligo lesions

  • K. Aroni
  • S. Voudouris
  • E. Ioannidis
  • A. Grapsa
  • N. Kavantzas
  • E. Patsouris
Original Paper


The larger number of T-lymphocytes in the periphery of vitiligo lesions and their association with angiogenesis are reported. The objective of this study was to investigate angiogenesis, VEGF and mast cell in vitiligo lesions. Specimens of 30 patients' biopsies, from lesional and perilesional nondepigmented skin were stained for mast cells, CD34 and VEGF. The evaluation was made by image analysis and the measured variables were statistically analyzed. A significantly increased number of CD34 and VEGF positive vessels and mast cells were detected in the centre of the lesion than in the periphery (p < 0.0001, p < 0.0001 and p = 0.001). There was a positive correlation of CD34, VEGF and mast cell number between the centre and the periphery of the lesions (r = 0.877, p < 0.0001; r = 0.946, p < 0.0001 and r = 0.863, p < 0.0001, respectively). The increased angiogenesis and mast cell numbers in the area where lymphocyte number is lower may be explained with the stepwise inflammatory process in vitiligo.


Vitiligo Angiogenesis Mast cells VEGF 


  1. 1.
    Al Badri AMT, Todd PM, Garioch JJ, Gudgeon JE, Stewart DG, Goudie RB (1993) An immunohistological study of cutaneous lymphocytes in vitiligo. J Pathol 170(2):149–155CrossRefGoogle Scholar
  2. 2.
    Aroni K, Tsagroni E, Kavantzas N, Patsouris E, Ioannidis E (2008) A study of the pathogenesis of rosacea: how angiogenesis and mast cells may participate in a complex multifactorial process. Arch Dermatol Res 300(3):125–131 Epub 2007 Dec 11CrossRefPubMedGoogle Scholar
  3. 3.
    Artuc M, Hermes B, Steckelings UM, Grützkau A, Henz BM (1999) Mast cells and their mediators in cutaneous wound healing–active participants or innocent bystanders? Exp Dermatol 8(1):1–16CrossRefPubMedGoogle Scholar
  4. 4.
    Bhushan M, McLaughlin B, Weiss JB, Griffiths CE (1999) Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis. Br J Dermatol 141(6):1054–1060CrossRefPubMedGoogle Scholar
  5. 5.
    Bradding P (1996) Human mast cell cytokines. Clin Exp Allergy 26(1):13–19CrossRefPubMedGoogle Scholar
  6. 6.
    Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HF, Senger DR (1993) Increased expression of vascular permeability factor (vascular endothelial growth factor), its receptors in kidney, bladder carcinomas. Am J Pathol 143(5):1255–1262PubMedGoogle Scholar
  7. 7.
    Cucchi ML, Frattini P, Santagostino G, Orecchia G (2000) Higher plasma catecholamine and metabolite levels in the early phase of nonsegmental vitiligo. Pigment Cell Res 13(1):28–32CrossRefPubMedGoogle Scholar
  8. 8.
    Dell’Anna ML, Urbanelli S, Mastrofrancesco A, Camera E, Iacovelli P, Leone G, Manini P, D’Ischia M, Picardo M (2003) Alterations of mitochondria in peripheral blood mononuclear cells of vitiligo patients. Pigment Cell Res 16(5):553–559CrossRefPubMedGoogle Scholar
  9. 9.
    Detmar M (1996) Molecular regulation of angiogenesis in the skin. J Invest Dermatol 106(2):207–208CrossRefPubMedGoogle Scholar
  10. 10.
    Freedberg IM, Fitzpatrick TB, Goldsmith LA, Austen KF (eds) (1999) Disorders of melanocytes, sect 12, chap 89. In: Fitzpatrick’s dermatology in general medicine, vol 1, 5th edn. Mc Graw-Hill, New York, pp 949–960Google Scholar
  11. 11.
    Furness SG, McNagny K (2006) Beyond mere markers: functions for CD34 family of sialomucins in hematopoiesis. Immunol Res 34(1):13–32CrossRefPubMedGoogle Scholar
  12. 12.
    Galli SJ (1993) New concepts about the mast cell. N Engl J Med 328(4):257–265CrossRefPubMedGoogle Scholar
  13. 13.
    Gauthier Y, Cario Andre M, Taïeb A (2003) A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res 16(4):322–332CrossRefPubMedGoogle Scholar
  14. 14.
    Gruber BL, Marchese MJ, Kew R (1995) Angiogenic factors stimulate mast-cell migration. Blood 86(7):2488–2493PubMedGoogle Scholar
  15. 15.
    Hasse S, Gibbons NC, Rokos H, Marles LK, Schallreuter KU (2004) Perturbed 6-tetrahydrobiopterin recycling via decreased dihydropteridine reductase in vitiligo: more evidence for H2O2 stress. J Invest Dermatol 122(2):307–313CrossRefPubMedGoogle Scholar
  16. 16.
    Imokawa G, Yada Y, Kimura M, Morisaki N (1996) Granulocyte/macrophage colony-stimulating factor is an intrinsic keratinocyte-derived growth factor for human melanocytes in UVA-induced melanosis. Biochem J 313(Pt 2):625–631PubMedGoogle Scholar
  17. 17.
    Jiang WY, Chattedee AD, Raychaudhuri SP, Raychaudhuri SK, Farber EM (2001) Mast cell density and IL-8 expression in nonlesional and lesional psoriatic skin. Int J Dermatol 40(11):699–703CrossRefPubMedGoogle Scholar
  18. 18.
    Knox CM, Rosacea SmolinG (1997) Int Ophthalmol Clin. Spring 37(2):29–40Google Scholar
  19. 19.
    Longley J, Duffy TP, Kohn S (1995) The mast cell and mast cell disease. J Am Acad Dermatol 32(4):545–561CrossRefPubMedGoogle Scholar
  20. 20.
    Marks RM, Roche WR, Czerniecki M, Penny R (1986) Nelson DS. Mast cell granules cause proliferation of human microvascular endothelial cells. Lab Invest 55(3):289–294PubMedGoogle Scholar
  21. 21.
    Mor F, Quintana FJ, Cohen IR (2004) Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. J Immunol 172(7):4618–4623PubMedGoogle Scholar
  22. 22.
    Moretti S, Spallanzani A, Amato L, Hautmann G, Gallerani I, Fabbri P (2002) Vitiligo and epidermal microenvironment: possible involvement of keratinocyte-derived cytokines. Arch Dermatol 138(2):273–274CrossRefPubMedGoogle Scholar
  23. 23.
    Moretti S, Spallanzani A, Amato L, Hautmann G, Gallerani I, Fabiani M, Fabbri P (2002) New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res 15(2):87–92CrossRefPubMedGoogle Scholar
  24. 24.
    Ortonne JP (2003) Pigmentary disorders. Vitiligo and other disorders of hypopigmentation. In: Bologna JL, Jorizzo JL, Rapini RP (eds) Dermotology, 2nd edn. Mosby, New York, pp 947–974Google Scholar
  25. 25.
    Oyarbide-Valencia Κ, van den Boorn JG, Denman CJ, Li M, Carlson JM, Hernandez C, Nishimura MI, Das PK, Luiten RM, Le Poole IC (2006) Therapeutic implications of autoimmune vitiligo T cells. Autoimmun Rev 5(7):486–492CrossRefPubMedGoogle Scholar
  26. 26.
    Probert L, Plows D, Kontogeorgos G, Kollias G (1995) The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice. Eur J Immunol 25(6):1794–1797CrossRefPubMedGoogle Scholar
  27. 27.
    Rothe MJ, Nowak M, Kerdel FA (1990) The mast cell in health and disease. J Am Acad Dermatol 23(4 Pt 1):615–624CrossRefPubMedGoogle Scholar
  28. 28.
    Schallreuter KU, Chiuchiarelli G, Cemeli E, Elwary SM, Gillbro JM, Spencer JD, Rokos H, Panske A, Chavan B, Wood JM, Anderson D (2006) Estrogens can contribute to hydrogen peroxide generation, quinone-mediated DNA damage in peripheral blood lymphocytes from patients with vitiligo. J Invest Dermatol 126(5):1036–1042CrossRefPubMedGoogle Scholar
  29. 29.
    Solano F, Briganti S, Picardo M, Ghanem G (2006) Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. Pigment Cell Res 19(6):550–571CrossRefPubMedGoogle Scholar
  30. 30.
    Steitz J, Wenzel J, Gaffal E, Tüting T (2004) Initiation regulation of CD8+ T cells recognizing melanocytic antigens in the epidermis: implications for the pathophysiology of vitiligo. Eur J Cell Biol 83(11–12):797–803CrossRefPubMedGoogle Scholar
  31. 31.
    Sugita K, Izu K, Tokura Y (2006) Vitiligo with inflammatory raised borders, associated with atopic dermatitis. Clin Exp Dermatol Jan 31(1):80–82CrossRefGoogle Scholar
  32. 32.
    Tharp MD (1991) The mast cell and its mediators. In: Goldsmith LA (ed) Physiology, biochemistry and molecular biology of the skin. Oxford University Press, New York, pp 1099–1120Google Scholar
  33. 33.
    van den Wijngaard R, Wankowicz-Kalinska A, Le Poole C, Tigges B, Westerhof W, Das P (2000) Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site. Lab Invest 80(8):1299–1309CrossRefPubMedGoogle Scholar
  34. 34.
    Weber S, Krüger-Krasagakes S, Grabbe J, Zuberbier T, Czarnetzki BM (1995) Mast cells. Int J Dermatol 34(1):1–10CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • K. Aroni
    • 1
  • S. Voudouris
    • 1
  • E. Ioannidis
    • 1
  • A. Grapsa
    • 1
  • N. Kavantzas
    • 1
  • E. Patsouris
    • 1
  1. 1.Department of DermatopathologyMedical School, National and Kapodistrian University of AthensAthensGreece

Personalised recommendations